PDCD1 and hepatocellular carcinoma: Survival analysis indicates that HCC patients with a higher number of DPT cells and PD‐1+ DPT cells experience significantly improved overall survival and recurrence‐free survival rates,[37] suggesting that the DPT cells are superior anti‐tumor T cells.